Cargando…

An optimised age-based dosing regimen for single low-dose primaquine for blocking malaria transmission in Cambodia

BACKGROUND: In 2012, the World Health Organization recommended the addition of single low-dose primaquine (SLDPQ, 0.25 mg base/kg body weight) to artemisinin combination therapies to block the transmission of Plasmodium falciparum without testing for glucose-6-phosphate dehydrogenase deficiency. The...

Descripción completa

Detalles Bibliográficos
Autores principales:	Leang, Rithea, Khu, Naw Htee, Mukaka, Mavuto, Debackere, Mark, Tripura, Rupam, Kheang, Soy Ty, Chy, Say, Kak, Neeraj, Buchy, Philippe, Tarantola, Arnaud, Menard, Didier, Roca-Felterer, Arantxa, Fairhurst, Rick M., Kheng, Sim, Muth, Sinoun, Ngak, Song, Dondorp, Arjen M., White, Nicholas J., Taylor, Walter Robert John
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2016
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5081959/ https://www.ncbi.nlm.nih.gov/pubmed/27784313 http://dx.doi.org/10.1186/s12916-016-0701-8

Ejemplares similares

Erratum to: An optimised age-based dosing regimen for single low-dose primaquine for blocking malaria transmission in Cambodia
por: Leang, Rithea, et al.
Publicado: (2016)

Development of weight and age-based dosing of daily primaquine for radical cure of vivax malaria
por: Taylor, Walter Robert, et al.
Publicado: (2021)

Dynamics of G6PD activity in patients receiving weekly primaquine for therapy of Plasmodium vivax malaria
por: Taylor, Walter R. J., et al.
Publicado: (2021)

Significant Efficacy of a Single Low Dose of Primaquine Compared to Stand-Alone Artemisinin Combination Therapy in Reducing Gametocyte Carriage in Cambodian Patients with Uncomplicated Multidrug-Resistant Plasmodium falciparum Malaria
por: Vantaux, Amélie, et al.
Publicado: (2020)

Single low-dose primaquine for blocking transmission of Plasmodium falciparum malaria – a proposed model-derived age-based regimen for sub-Saharan Africa
por: Taylor, W. Robert, et al.
Publicado: (2018)

Pharmacokinetics of single low dose primaquine in Ugandan and Congolese children with falciparum malaria
por: Mukaka, Mavuto, et al.
Publicado: (2023)

The tolerability of single low dose primaquine in glucose-6-phosphate deficient and normal falciparum-infected Cambodians
por: Dysoley, Lek, et al.
Publicado: (2019)

Editorial Commentary: Single-Dose Primaquine as Gametocytocidal Treatment in Patients With Uncomplicated Falciparum Malaria
por: Dondorp, Arjen M.
Publicado: (2013)

Single Low Dose Primaquine (0.25mg/kg) Does Not Cause Clinically Significant Haemolysis in G6PD Deficient Subjects
por: Bancone, Germana, et al.
Publicado: (2016)

The dynamic of asymptomatic Plasmodium falciparum infections following mass drug administrations with dihydroarteminisin–piperaquine plus a single low dose of primaquine in Savannakhet Province, Laos
por: Pongvongsa, Tiengkham, et al.
Publicado: (2018)

Hemolytic Dynamics of Weekly Primaquine Antirelapse Therapy Among Cambodians With Acute Plasmodium vivax Malaria With or Without Glucose-6-Phosphate Dehydrogenase Deficiency
por: Taylor, Walter R J, et al.
Publicado: (2019)

Reducing the spread of artemisinin resistant malaria through community-level directly observed therapy in Western of Cambodia
por: Say, Chy, et al.
Publicado: (2012)

Corrigendum to: Hemolytic Dynamics of Weekly Primaquine Antirelapse Therapy Among Cambodians With Acute Plasmodium vivax Malaria With or Without Glucose-6-Phosphate Dehydrogenase Deficiency
por: Taylor, Walter R J, et al.
Publicado: (2020)

Mass drug administrations with dihydroartemisinin-piperaquine and single low dose primaquine to eliminate Plasmodium falciparum have only a transient impact on Plasmodium vivax: Findings from randomised controlled trials
por: Phommasone, Koukeo, et al.
Publicado: (2020)

Factors affecting haemoglobin dynamics in African children with acute uncomplicated Plasmodium falciparum malaria treated with single low-dose primaquine or placebo
por: Onyamboko, Marie A., et al.
Publicado: (2023)

Safety, Pharmacokinetics, and Mosquito‐Lethal Effects of Ivermectin in Combination With Dihydroartemisinin‐Piperaquine and Primaquine in Healthy Adult Thai Subjects
por: Kobylinski, Kevin C., et al.
Publicado: (2019)

Pharmacovigilance for single low-dose primaquine: a practical approach
por: Poirot, Eugenie, et al.
Publicado: (2014)

Pharmacokinetics of single-dose primaquine in patients with chronic kidney dysfunction
por: Kulkarni, Shaunak P., et al.
Publicado: (2013)

Higher-Dose Primaquine to Prevent Relapse of Plasmodium vivax Malaria
por: Watson, James A., et al.
Publicado: (2022)

Modelling the therapeutic dose range of single low dose primaquine to reduce malaria transmission through age-based dosing
por: Hayes, Daniel Joseph, et al.
Publicado: (2017)

Identifying risk factors for the development of sepsis during adult severe malaria
por: Njim, Tsi, et al.
Publicado: (2018)

An algorithm applied to national surveillance data for the early detection of major dengue outbreaks in Cambodia
por: Ledien, Julia, et al.
Publicado: (2019)

Primaquine at alternative dosing schedules for preventing relapse in people with Plasmodium vivax malaria
por: Milligan, Rachael, et al.
Publicado: (2019)

Assessment of net lending strategy to better reach mobile and migrant populations in malaria endemic areas of Cambodia
por: Lek, Dysoley, et al.
Publicado: (2018)

Intracluster correlation coefficients in the Greater Mekong Subregion for sample size calculations of cluster randomized malaria trials
por: Peerawaranun, Pimnara, et al.
Publicado: (2019)

The use of ultrasensitive quantitative-PCR to assess the impact of primaquine on asymptomatic relapse of Plasmodium vivax infections: a randomized, controlled trial in Lao PDR
por: Phommasone, Koukeo, et al.
Publicado: (2020)

Tolerability and safety of weekly primaquine against relapse of Plasmodium vivax in Cambodians with glucose-6-phosphate dehydrogenase deficiency
por: Kheng, Sim, et al.
Publicado: (2015)

Low Circulation of Zika Virus, Cambodia, 2007–2016
por: Duong, Veasna, et al.
Publicado: (2017)

Low-dose primaquine to reduce the transmission of P. falciparum malaria: a roadmap update
por: Chen, Ingrid, et al.
Publicado: (2014)

Relapse of imported Plasmodium vivax malaria is related to primaquine dose: a retrospective study
por: Townell, Nicola, et al.
Publicado: (2012)

Comparative single dose pharmacokinetics and metabolism of racemic primaquine and its enantiomers in human volunteers
por: Khan, Washim, et al.
Publicado: (2022)

Correction to: The use of ultrasensitive quantitative-PCR to assess the impact of primaquine on asymptomatic relapse of Plasmodium vivax infections: a randomized, controlled trial in Lao PDR
por: Phommasone, Koukeo, et al.
Publicado: (2020)

Chloroquine Versus Dihydroartemisinin-Piperaquine With Standard High-dose Primaquine Given Either for 7 Days or 14 Days in Plasmodium vivax Malaria
por: Chu, Cindy S, et al.
Publicado: (2019)

Evaluation of community-based systems for the surveillance of day three-positive Plasmodium falciparum cases in Western Cambodia
por: Cox, Jonathan, et al.
Publicado: (2014)

A Competing-Risk Approach for Modeling Length of Stay in Severe Malaria Patients in South-East Asia and the Implications for Planning of Hospital Services
por: Keene, Claire M, et al.
Publicado: (2018)

Effect of High-Dose or Split-Dose Artesunate on Parasite Clearance in Artemisinin-Resistant Falciparum Malaria
por: Das, Debashish, et al.
Publicado: (2013)

Primaquine Pharmacokinetics in Lactating Women and Breastfed Infant Exposures
por: Gilder, Mary Ellen, et al.
Publicado: (2018)

Correction to: Prevalence of K13 mutation and Day-3 positive parasitaemia in artemisinin-resistant malaria endemic area of Cambodia: a cross-sectional study
por: Kheang, Soy Ty, et al.
Publicado: (2017)

Prevalence of K13 mutation and Day-3 positive parasitaemia in artemisinin-resistant malaria endemic area of Cambodia: a cross-sectional study
por: Kheang, Soy Ty, et al.
Publicado: (2017)

Primaquine double dose for 7 days is inferior to single-dose treatment for 14 days in preventing Plasmodium vivax recurrent episodes in Suriname
por: Mac Donald-Ottevanger, M Sigrid, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_d7m3j8eiefd4heqgs59iqljfhm